System Transmission

Top Signal

100#1 JOB

Activity

2187Ripe

+945 today

System

Live1m

Terminal Asset View

stockNASDAQ

CAPR

$30.50-8.74%

Capricor Therapeutics Inc

Too-Late

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

50Too-Late

Live Analysis Active

Company Mission

Capricor Therapeutics creates cell-based treatments for heart diseases like Duchenne muscular dystrophy. Doctors and hospitals use these therapies to help patients with limited options, and the company earns money from clinical trials, grants, and collaborations with other biotech firms.

CAP

Industry Context

Capricor operates in the biotechnology sector, focusing on regenerative medicine for heart conditions. This industry is highly competitive and driven by clinical trial outcomes and regulatory approvals. Companies often rely on partnerships and funding to advance research, making them sensitive to news and investor sentiment.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

67Matrix

Market Momentum

58.5— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.7x— Normal Volume

Today's Change

-8.74%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

Gap Exposure-1

Large opening gap indicates potential short-term exhaustion.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing CAPR across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:52 AM UTC

As-of As of 2026-03-16T06:36:54.257Z UTC (~15m delay).

Develops cell therapies for heart diseases, generating revenue through clinical trials and partnerships with hospitals and biotech firms.

No technical data available, but watch for price movements above $31 as a potential signal of investor confidence in upcoming trial results.

No volume data available, but monitor if trading activity increases near $0, indicating heightened interest from speculators awaiting news.

Biotech sector trends favor innovative treatments, with price needing to hold above $0 to avoid further declines amid high industry volatility.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...